{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:03:45Z","timestamp":1769857425229,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T00:00:00Z","timestamp":1479081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/pr.2016.241","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T19:28:10Z","timestamp":1479151690000},"page":"473-479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity"],"prefix":"10.1038","volume":"81","author":[{"given":"Luz Consuelo","family":"Zepeda-Romero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Vazquez-Membrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elva","family":"Adan-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Gomez-Aguayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Alfonso","family":"Gutierrez-Padilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eusebio","family":"Angulo-Castellanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Barrera de Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesareo","family":"Gonzalez-Bernal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Alejandro","family":"Quezada-Chalita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alonso","family":"Meza-Anguiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nundehui","family":"Diaz-Lezama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Martinez de la Escalera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Triebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Clapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,14]]},"reference":[{"key":"BFpr2016241_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1053\/j.nainr.2013.09.003","volume":"13","author":"K Friddle","year":"2013","unstructured":"Friddle K. Pathogenesis of retinopathy of prematurity: Does inflamation play a role? Newborn Infant Nurs Rev 2013; 13:161\u2013165.","journal-title":"Newborn Infant Nurs Rev"},{"key":"BFpr2016241_CR2","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","volume":"382","author":"A Hellstr\u00f6m","year":"2013","unstructured":"Hellstr\u00f6m A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet 2013;382:1445\u201357.","journal-title":"Lancet"},{"key":"BFpr2016241_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archophthalmol.2010.65","volume":"128","author":"SJ Budd","year":"2010","unstructured":"Budd SJ, Hartnett ME. Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity. Arch Ophthalmol 2010;128:589\u201395.","journal-title":"Arch Ophthalmol"},{"key":"BFpr2016241_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/aos.12266","volume":"92","author":"BC Harder","year":"2014","unstructured":"Harder BC, von Baltz S, Jonas JB, Schlichtenbrede FC. Intravitreal low-dosage bevacizumab for retinopathy of prematurity. Acta Ophthalmol 2014;92:577\u201381.","journal-title":"Acta Ophthalmol"},{"key":"BFpr2016241_CR5","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ophtha.2008.12.023","volume":"116","author":"T Sato","year":"2009","unstructured":"Sato T, Kusaka S, Shimojo H, Fujikado T. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Ophthalmology 2009;116:1599\u2013603.","journal-title":"Ophthalmology"},{"key":"BFpr2016241_CR6","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","volume":"112","author":"A Hellstr\u00f6m","year":"2003","unstructured":"Hellstr\u00f6m A, Engstr\u00f6m E, H\u00e5rd AL, et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 2003;112:1016\u201320.","journal-title":"Pediatrics"},{"key":"BFpr2016241_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-319-12114-7_4","volume":"846","author":"C Clapp","year":"2015","unstructured":"Clapp C, Thebault S, Macotela Y, Moreno-Carranza B, Triebel J, Mart\u00ednez de la Escalera G. Regulation of blood vessels by prolactin and vasoinhibins. Adv Exp Med Biol 2015;846:83\u201395.","journal-title":"Adv Exp Med Biol"},{"key":"BFpr2016241_CR8","doi-asserted-by":"publisher","first-page":"R1193","DOI":"10.1152\/ajpregu.00256.2015","volume":"309","author":"J Triebel","year":"2015","unstructured":"Triebel J, Bertsch T, Bollheimer C, et al. Principles of the prolactin\/vasoinhibin axis. Am J Physiol Regul Integr Comp Physiol 2015;309:R1193\u2013203.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFpr2016241_CR9","first-page":"2498","volume":"40","author":"Z Due\u00f1as","year":"1999","unstructured":"Due\u00f1as Z, Torner L, Corbacho AM, et al. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules. Invest Ophthalmol Vis Sci 1999;40:2498\u2013505.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016241_CR10","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1167\/iovs.05-0173","volume":"46","author":"J Aranda","year":"2005","unstructured":"Aranda J, Rivera JC, Jeziorski MC, et al. Prolactins are natural inhibitors of angiogenesis in the retina. Invest Ophthalmol Vis Sci 2005;46:2947\u201353.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016241_CR11","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.2337\/db10-0873","volume":"59","author":"E Arnold","year":"2010","unstructured":"Arnold E, Rivera JC, Thebault S, et al. High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins. Diabetes 2010;59:3192\u20137.","journal-title":"Diabetes"},{"key":"BFpr2016241_CR12","first-page":"2291","volume":"118","author":"C Garc\u00eda","year":"2008","unstructured":"Garc\u00eda C, Aranda J, Arnold E, et al. Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation. J Clin Invest 2008;118:2291\u2013300.","journal-title":"J Clin Invest"},{"key":"BFpr2016241_CR13","doi-asserted-by":"publisher","first-page":"8944","DOI":"10.1167\/iovs.11-8190","volume":"52","author":"M Ram\u00edrez","year":"2011","unstructured":"Ram\u00edrez M, Wu Z, Moreno-Carranza B, et al. Vasoinhibin gene transfer by adenoassociated virus type 2 protects against VEGF- and diabetes-induced retinal vasopermeability. Invest Ophthalmol Vis Sci 2011;52:8944\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016241_CR14","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1167\/iovs.03-1001","volume":"45","author":"H Pan","year":"2004","unstructured":"Pan H, Nguyen NQ, Yoshida H, et al. Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice. Invest Ophthalmol Vis Sci 2004;45:2413\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016241_CR15","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1167\/iovs.03-1346","volume":"45","author":"Z Due\u00f1as","year":"2004","unstructured":"Due\u00f1as Z, Rivera JC, Quir\u00f3z-Mercado H, et al. Prolactin in eyes of patients with retinopathy of prematurity: implications for vascular regression. Invest Ophthalmol Vis Sci 2004;45:2049\u201355.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016241_CR16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/0002-9378(89)90404-3","volume":"161","author":"CR Parker Jr","year":"1989","unstructured":"Parker CR Jr, MacDonald PC, Guzick DS, Porter JC, Rosenfeld CR, Hauth JC. Prolactin levels in umbilical cord blood of human infants: relation to gestational age, maternal complications, and neonatal lung function. Am J Obstet Gynecol 1989;161:795\u2013802.","journal-title":"Am J Obstet Gynecol"},{"key":"BFpr2016241_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/labinvest.3700662","volume":"87","author":"C Gonz\u00e1lez","year":"2007","unstructured":"Gonz\u00e1lez C, Parra A, Ram\u00edrez-Peredo J, et al. Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia. Lab Invest 2007;87:1009\u201317.","journal-title":"Lab Invest"},{"key":"BFpr2016241_CR18","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1210\/jc.2008-0305","volume":"93","author":"A Lea\u00f1os-Miranda","year":"2008","unstructured":"Lea\u00f1os-Miranda A, M\u00e1rquez-Acosta J, C\u00e1rdenas-Mondrag\u00f3n GM, et al. Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes. J Clin Endocrinol Metab 2008;93:2492\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFpr2016241_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","volume":"128","author":"D Hilfiker-Kleiner","year":"2007","unstructured":"Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16\u2009kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007;128:589\u2013600.","journal-title":"Cell"},{"key":"BFpr2016241_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the Classification of Retinopathy of P.","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of P. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005; 123:991\u2013999.","journal-title":"Arch Ophthalmol"},{"key":"BFpr2016241_CR21","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1210\/me.2004-0200","volume":"18","author":"D Piwnica","year":"2004","unstructured":"Piwnica D, Touraine P, Struman I, et al. Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance. Mol Endocrinol 2004;18:2522\u201342.","journal-title":"Mol Endocrinol"},{"key":"BFpr2016241_CR22","first-page":"549","volume":"81","author":"JT Flynn","year":"1983","unstructured":"Flynn JT. Acute proliferative retrolental fibroplasia: multivariate risk analysis. Trans Am Ophthalmol Soc 1983;81:549\u201391.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"BFpr2016241_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/pr.2015.181","volume":"79","author":"G Hellgren","year":"2016","unstructured":"Hellgren G, L\u00f6fqvist C, H\u00e5rd AL, et al. Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity. Pediatr Res 2016;79:70\u20135.","journal-title":"Pediatr Res"},{"key":"BFpr2016241_CR24","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2147\/OPTH.S11650","volume":"4","author":"R Velez-Montoya","year":"2010","unstructured":"Velez-Montoya R, Clapp C, Rivera JC, et al. Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity. Clin Ophthalmol 2010;4:947\u201353.","journal-title":"Clin Ophthalmol"},{"key":"BFpr2016241_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9378(72)90446-2","volume":"113","author":"JE Tyson","year":"1972","unstructured":"Tyson JE, Hwang P, Guyda H, Friesen HG. Studies of prolactin secretion in human pregnancy. Am J Obstet Gynecol 1972;113:14\u201320.","journal-title":"Am J Obstet Gynecol"},{"key":"BFpr2016241_CR26","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1210\/jcem-41-3-626","volume":"41","author":"AJ Winters","year":"1975","unstructured":"Winters AJ, Colston C, MacDonald PC, Porter JC. Fetal plasma prolactin levels. J Clin Endocrinol Metab 1975;41:626\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFpr2016241_CR27","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1210\/jcem-51-5-1019","volume":"51","author":"N Ben-Jonathan","year":"1980","unstructured":"Ben-Jonathan N, Munsick RA. Dopamine and prolactin in human pregnancy. J Clin Endocrinol Metab 1980;51:1019\u201325.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFpr2016241_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1203\/00006450-197305000-00007","volume":"7","author":"HJ Guyda","year":"1973","unstructured":"Guyda HJ, Friesen HG. Serum prolactin levels in humans from birth to adult life. Pediatr Res 1973;7:534\u201340.","journal-title":"Pediatr Res"},{"key":"BFpr2016241_CR29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1136\/adc.65.9.977","volume":"65","author":"A Lucas","year":"1990","unstructured":"Lucas A, Baker BA, Cole TJ. Plasma prolactin and clinical outcome in preterm infants. Arch Dis Child 1990;65:977\u201383.","journal-title":"Arch Dis Child"},{"key":"BFpr2016241_CR30","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1167\/iovs.04-1489","volume":"46","author":"L Notari","year":"2005","unstructured":"Notari L, Miller A, Mart\u00ednez A, et al. Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia. Invest Ophthalmol Vis Sci 2005;46:2736\u201347.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016241_CR31","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.1167\/iovs.11-7666","volume":"52","author":"W Zhang","year":"2011","unstructured":"Zhang W, Yokota H, Xu Z, et al. Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model. Invest Ophthalmol Vis Sci 2011;52:6384\u201395.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt 9","key":"BFpr2016241_CR32","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1242\/jcs.02887","volume":"119","author":"Y Macotela","year":"2006","unstructured":"Macotela Y, Aguilar MB, Guzm\u00e1n-Morales J, et al. Matrix metalloproteases from chondrocytes generate an antiangiogenic 16\u2009kDa prolactin. J Cell Sci 2006;119(Pt 9):1790\u2013800.","journal-title":"J Cell Sci"},{"key":"BFpr2016241_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0039-6257(83)90125-X","volume":"27","author":"S Hayasaka","year":"1983","unstructured":"Hayasaka S. Lysosomal enzymes in ocular tissues and diseases. Surv Ophthalmol 1983;27:245\u201358.","journal-title":"Surv Ophthalmol"},{"key":"BFpr2016241_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jprot.2012.07.014","volume":"77","author":"YH Chen","year":"2012","unstructured":"Chen YH, Chou HC, Lin ST, Chen YW, Lo YW, Chan HL. Effect of high glucose on secreted proteome in cultured retinal pigmented epithelium cells: its possible relevance to clinical diabetic retinopathy. J Proteomics 2012;77:111\u201328.","journal-title":"J Proteomics"},{"key":"BFpr2016241_CR35","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/endo-122-6-2892","volume":"122","author":"C Clapp","year":"1988","unstructured":"Clapp C, Sears PS, Russell DH, Richards J, Levay-Young BK, Nicoll CS. Biological and immunological characterization of cleaved and 16K forms of rat prolactin. Endocrinology 1988;122:2892\u20138.","journal-title":"Endocrinology"},{"key":"BFpr2016241_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000265174","volume":"14","author":"WK O\u2019Steen","year":"1982","unstructured":"O\u2019Steen WK, Sundberg DK. Patterns of radioactivity in the eyes of rats after injection of iodinated prolactin. Ophthalmic Res 1982;14:54\u201362.","journal-title":"Ophthalmic Res"},{"key":"BFpr2016241_CR37","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1523\/JNEUROSCI.2452-13.2014","volume":"34","author":"E Arnold","year":"2014","unstructured":"Arnold E, Thebault S, Baeza-Cruz G, et al. The hormone prolactin is a novel, endogenous trophic factor able to regulate reactive glia and to limit retinal degeneration. J Neurosci 2014;34:1868\u201378.","journal-title":"J Neurosci"},{"key":"BFpr2016241_CR38","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1167\/iovs.14-15842","volume":"56","author":"L Kong","year":"2015","unstructured":"Kong L, Bhatt AR, Demny AB, et al. Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity. Invest Ophthalmol Vis Sci 2015;56:956\u201361.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016241_CR39","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/bjo.2007.128371","volume":"92","author":"C Pieh","year":"2008","unstructured":"Pieh C, Agostini H, Buschbeck C, et al. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity. Br J Ophthalmol 2008;92:689\u201393.","journal-title":"Br J Ophthalmol"},{"key":"BFpr2016241_CR40","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1167\/iovs.13-11837","volume":"54","author":"SJ Woo","year":"2013","unstructured":"Woo SJ, Park KH, Lee SY, et al. The relationship between cord blood cytokine levels and perinatal factors and retinopathy of prematurity: a gestational age-matched case-control study. Invest Ophthalmol Vis Sci 2013;54:3434\u20139.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2016241.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2016241","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2016241.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:31Z","timestamp":1684616491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2016241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,14]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFpr2016241"],"URL":"https:\/\/doi.org\/10.1038\/pr.2016.241","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,14]]},"assertion":[{"value":"15 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}